Publication | Open Access
A Randomized Study of H3 Antagonist ABT-288 in Mild-To-Moderate Alzheimer's Dementia1
70
Citations
35
References
2014
Year
ABT-288 did not demonstrate efficacy in the symptomatic treatment of Alzheimer's dementia.
| Year | Citations | |
|---|---|---|
Page 1
Page 1